ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
Dow Jones
38.225,66
0,85%
Euro vs US Dollar
1,07371
0,07%
Bitcoin
59.346,26
0,38%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Acurx Pharmaceuticals Inc (ACXP)

  7. Acurx Pharmaceuticals Inc (ACXP) News

ACXP Acurx Pharmaceuticals Inc

2,12
-0,04 (-1,85%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Acurx Pharmaceuticals Inc ACXP NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,04 -1,85% 2,12 01:50:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,15 2,06 2,22 2,12 2,16
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202413:00PRNUSAcurx Pharmaceuticals Announces Presentation of Ibezapolstat..
25.4.202416:12PRNUSAcurx Pharmaceuticals Announces Presentation of..
23.4.202416:57PRNUSAcurx Pharmaceuticals, Inc. to Discuss First Quarter 2024..
19.3.202412:33IHMARKETNEWSUnilever Initiates Ice Cream Division Spin-Off and Announces..
18.3.202412:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
18.3.202412:01PRNUSAcurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full..
04.3.202413:01PRNUSAcurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and..
27.2.202413:01PRNUSAcurx Announces FDA Has Granted an End of Phase 2 Meeting..
23.2.202415:30GLOBENew to The Street Announces Line-up of its Corporate..
16.2.202415:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
02.2.202415:30GLOBENew to The Street Announces its 553rd Episode TV Line Up,..
01.2.202415:33GLOBENew to The Street TV Announces Episode #552 with its Five..
29.1.202413:00PRNUSAcurx Announces Positive Extended Clinical Cure Data for..
26.1.202416:55GLOBENew to The Street Announces Episode 551, Five Corporate..
23.1.202413:01PRNUSAcurx Pharmaceuticals to Present at the Microcap Conference,..
22.1.202412:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202415:30GLOBENew to The Street Airs on the FOX Business Network, Episode..
17.1.202413:01PRNUSAcurx Announces Positive Comparative Microbiology and..
05.1.202415:30GLOBENew to The Street Announces its Four Corporate Interviews,..
03.1.202414:00PRNUSAcurx to present at the 42nd Annual J.P. Morgan Healthcare..
11.12.202313:01PRNUSAcurx Announces Positive Phase 2b Results Showing 100% of..
08.12.202315:46GLOBENew to The Street TV Features Five Corporate Guest..
07.12.202315:20GLOBENew to The Street TV Announces Its Episode 536 Lineup, Five..
01.12.202315:30GLOBENew to The Street Announces Five Corporate Interviews,..
24.11.202315:30GLOBENew to The Street Announces its Five Business Guest..
17.11.202315:30GLOBENew to The Street Announces Episode 530 with Six Corporate..
15.11.202323:02EDGAR2Form 8-K - Current report
15.11.202322:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14.11.202313:01PRNUSAcurx Pharmaceuticals, Inc. Reports Third Quarter 2023..
02.11.202312:01PRNUSAcurx Announces Positive Top-Line Ibezapolstat Phase 2..
25.10.202313:01PRNUSAcurx Pharmaceuticals to Discuss Third Quarter 2023..
20.10.202316:43GLOBENew to The Street Announces Six Business Interviews on its..
19.10.202313:01PRNUSAcurx Announces Ibezapolstat Scientific Posters and..
02.10.202313:01PRNUSAcurx Pharmaceuticals Announces Successful Completion and..
12.9.202313:01PRNUSAcurx Announces Presentation and Update of Its pol IIIC R&D..
22.8.202313:01PRNUSAcurx Pharmaceuticals to Present at the H.C. Wainwright 25th..
14.8.202313:01PRNUSAcurx Pharmaceuticals, Inc. Reports Second Quarter 2023..
24.7.202313:01PRNUSAcurx Pharmaceuticals to Discuss Second Quarter 2023..
13.7.202322:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11.7.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
07.7.202315:30GLOBENew to The Street Airs its Televised Corporate Interviews on..
30.6.202315:35GLOBENew to The Street TV / Newsmax TV Announces its Five..
20.6.202313:01PRNUSAcurx Pharmaceuticals to Present at the Emerging Growth..
15.6.202313:01PRNUSAcurx Pharmaceuticals to Participate in the Maxim Group LLC..
16.5.202314:45PRNUSAcurx Pharmaceuticals, Inc. Announces Pricing of $4.0..
12.5.202313:01PRNUSAcurx Pharmaceuticals, Inc. Reports First Quarter 2023..
05.5.202323:01PRNUSAcurx Pharmaceuticals to Discuss First Quarter 2023..

Kürzlich von Ihnen besucht

NASDAQ
ACXP
Acurx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten